MULTIPLE-VARIABLE DOSE REGIMEN FOR TREATING TNFalpha-RELATED DISORDERS
Multiple-variable dose methods for treating TNFa-related disorders, including Crohn's disease and psoriasis, comprising administering TNFa inhibitors, including TNFa antibodies, are described. Multiple-variable dose methods include administration of a TNF-inhibitor in an induction or loading ph...
Saved in:
Main Authors | , , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
11.11.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Multiple-variable dose methods for treating TNFa-related disorders, including Crohn's disease and psoriasis, comprising administering TNFa inhibitors, including TNFa antibodies, are described. Multiple-variable dose methods include administration of a TNF-inhibitor in an induction or loading phase followed by administration of the agent in a maintenance or treatment phase, wherein the TNF-inhibitor is administered in a higher dosage during the induction phase. |
---|---|
AbstractList | Multiple-variable dose methods for treating TNFa-related disorders, including Crohn's disease and psoriasis, comprising administering TNFa inhibitors, including TNFa antibodies, are described. Multiple-variable dose methods include administration of a TNF-inhibitor in an induction or loading phase followed by administration of the agent in a maintenance or treatment phase, wherein the TNF-inhibitor is administered in a higher dosage during the induction phase. |
Author | Taylor, Lori K Paulson, Susan K Hoffman, Rebecca S Peng, Joanna Z Chartash, Elliot Keith Granneman, George Richard Yan, Philip |
Author_xml | – fullname: Peng, Joanna Z – fullname: Paulson, Susan K – fullname: Chartash, Elliot Keith – fullname: Hoffman, Rebecca S – fullname: Granneman, George Richard – fullname: Yan, Philip – fullname: Taylor, Lori K |
BookMark | eNqNyrsKwjAUANAMOvj6hwvOAdsqdY3mpgbSRm5S1xIk4lDSQP1_XPwAp7OcNVukKcUVU21vvL4b5A9BWlwMgrQOgbDRLXagLIEnFF53DfhOhTG_Ayc0wqMEqZ0lieS2bPkK4xx3Pzdsr9BfbzzmaYhzDs-Y4mfoXXkoi-pYn-uTKKr_1hfeoy_O |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | US2021347875A1 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_US2021347875A13 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 14:54:23 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_US2021347875A13 |
Notes | Application Number: US202017125275 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20211111&DB=EPODOC&CC=US&NR=2021347875A1 |
ParticipantIDs | epo_espacenet_US2021347875A1 |
PublicationCentury | 2000 |
PublicationDate | 20211111 |
PublicationDateYYYYMMDD | 2021-11-11 |
PublicationDate_xml | – month: 11 year: 2021 text: 20211111 day: 11 |
PublicationDecade | 2020 |
PublicationYear | 2021 |
RelatedCompanies | ABBVIE BIOTECHNOLOGY LTD |
RelatedCompanies_xml | – name: ABBVIE BIOTECHNOLOGY LTD |
Score | 3.370348 |
Snippet | Multiple-variable dose methods for treating TNFa-related disorders, including Crohn's disease and psoriasis, comprising administering TNFa inhibitors,... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | MULTIPLE-VARIABLE DOSE REGIMEN FOR TREATING TNFalpha-RELATED DISORDERS |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20211111&DB=EPODOC&locale=&CC=US&NR=2021347875A1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3PS8MwFH6MKepNp-J0SkDprbiuzdYdinRtulXWbvTH2G00bQaCdMNV_PdNQqc77ZbkQUgC7yVfku97AC99ins4KzJVy6i4raKGSlnGVNYdFmuz0IcmFmzkIOxPUuN9iZcN-NxzYaRO6I8UR-QelXN_r2S83v5fYrnyb-XulX7wps2bl1iuUqPjnggAmuKOLDKfuTNHcRwrjZUwkjZdCNFgm2OlE3GQFkr7ZDESvJTt4abiXcLpnPdXVlfQYGULzp197rUWnAX1kzcv1t63uwYvSKeJP58SdWFHvj2aEuTOYoIiMvYDEiIO6FASETvxwzFKQk_yaFWRFIOHJ-T6MQd8JIpv4NkjiTNR-YBWf_NfpfHh6PVbaJabkt0B0opiPegKPRxMjZytzQHV82Evz7WBbjKctaFzrKf74-YHuBBVQbzTtA40q69v9sh34Io-yYX7Bb88hLQ |
link.rule.ids | 230,309,786,891,25594,76903 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da8IwED_Ejbm3zW3sw22Bjb6VWWtsfZBR21S7tVX6Ib5J00YYjCqzY__-kqCbT76FHByXwN3xu-R3B_Dco7iDsyJTtYyKahXtqpRlTGXtfrE0C71vYsFGDsLeOO2-zfG8Bp87LozsE_ojmyNyj8q5v1cyXq__i1iO_Fu5eaEffGv16iYDR9mi444IAJriDAdkOnEmtmLbgzRWwkjKdNGIBlscKx0ZHBRKsDQbCl7Kej-puGdwPOX6yuocaqxsQsPezV5rwkmwffLmy633bS7ADVI_8aY-UWdW5FlDnyBnEhMUkZEXkBBxQIeSiFiJF45QErqSR6uKoRg8PCHHizngI1F8CU8uSeyxyg1a_J1_kcb71utXUC9XJbsGpBXF0miLfjiYdnO2NA2q5_1OnmuGbjKc3UDrkKbbw-JHaIyTwF_4Xvh-B6dCJEh4mtaCevX1ze55Nq7og7zEXxlFh54 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=MULTIPLE-VARIABLE+DOSE+REGIMEN+FOR+TREATING+TNFalpha-RELATED+DISORDERS&rft.inventor=Peng%2C+Joanna+Z&rft.inventor=Paulson%2C+Susan+K&rft.inventor=Chartash%2C+Elliot+Keith&rft.inventor=Hoffman%2C+Rebecca+S&rft.inventor=Granneman%2C+George+Richard&rft.inventor=Yan%2C+Philip&rft.inventor=Taylor%2C+Lori+K&rft.date=2021-11-11&rft.externalDBID=A1&rft.externalDocID=US2021347875A1 |